ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk gets approval to carry out clinical trials on weekly insulin
Novo Nordisk has received approval from the Drug Controller General of India to conduct phase-III studies for its new weekly insulin injection, IcoSema, in India. IcoSema is a combination of insulin and Semaglutide and is meant to control blood sugar level
Announcement as on 20 October 2023

Novo Nordisk (NVO) Raises Sales Outlook for 2023, Shares Gain
Novo Nordisk NVO upped its sales and operating profit forecast for 2023 yet again on the back of higher demand for diabetes drug Ozempic (semaglutide) and obesity drug Wegovy. 
Announcement as on 16 October 2023

: Novo Nordisk to buy hypertension treatment from for .3 billion from KBP Biosciences
Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay .3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is a pill that also has potential application for cardiovascular and kidney disease. The Denmark-based biote
Announcement as on 16 October 2023

: Novo Nordisk boosts sales and profit outlook, buoyed by Ozempic and Wegovy
Novo Nordisk NVO on Friday boosted its full-year 2023 profit and sales outlook, reflecting heightened expectations for Ozempic and Wegovy sales. The company now projects full-year sales growth of 32% to 38%, up from 27% to 33% previously, and operating pro
Announcement as on 13 October 2023

European stocks edge up as Novo Nordisk offsets luxury sector jitters
​European stocks inched higher on Wednesday as Novo Nordisk shares jumped after a positive update on its diabetes drug Ozempic, though underwhelming results from French luxury giant LVMH capped gains.
Announcement as on 11 October 2023

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 41.75
  • 12Day Average: 40.74
  • 20Day Average: 39.66
  • 50Day Average: 38.86
  • 100Day Average: 46.13
  • 150Day Average: 48.06
  • 200Day Average: 50.32

NVO Indicators & signals

Indicator MACD (12,26,9)

40.84, 40.01, 0.33
Indicator MACD is in positive zone

Indicator ADX (14)

27.47, 38.93, 22.15
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
01 Fri May 2026 43.88 43.10 to 44.04 3.93% 1.53 times
30 Thu Apr 2026 42.22 41.65 to 42.86 4.79% 1.47 times
29 Wed Apr 2026 40.29 39.70 to 40.78 -2.14% 0.95 times
28 Tue Apr 2026 41.17 41.10 to 42.08 -0.05% 0.96 times
27 Mon Apr 2026 41.19 40.55 to 41.73 0.05% 0.97 times
24 Fri Apr 2026 41.17 38.22 to 41.23 6.88% 1.2 times
23 Thu Apr 2026 38.52 38.02 to 39.20 -1.61% 0.72 times
22 Wed Apr 2026 39.15 38.85 to 39.33 -0.68% 1.02 times
21 Tue Apr 2026 39.42 38.70 to 40.20 -2.59% 1.47 times
20 Mon Apr 2026 40.47 39.75 to 40.85 -0.12% 0.47 times
17 Fri Apr 2026 40.52 40.43 to 41.29 -1% 0.77 times
16 Thu Apr 2026 40.93 40.23 to 41.66 0.29% 0.73 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared USA

 

Back to top